RA0511

antibody from Oursmab

Targeting: MSTN GDF8

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0511

Provider

Oursmab

Product name

Landogrozumab (Biosimilar Reference Antibody) (MSTN)

Antibody type

Monoclonal

Description

Landogrozumab is a humanized monoclonal antibody designed to target and neutralize myostatin (GDF8), a negative regulator of skeletal muscle growth. By binding to myostatin, it blocks its interaction with the activin type II receptor (ActRIIB), thereby aiming to promote muscle hypertrophy and prevent muscle loss. It has been investigated in clinical trials for conditions involving muscle atrophy and wasting, such as sarcopenia in older adults and cachexia associated with cancer.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Landogrozumab (Biosimilar Reference Antibody) (MSTN)-RA0511-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.

ELISA

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

ELISA plate pre-coated Antigen protein, can bind Landogrozumab (Biosimilar Reference Antibody) (MSTN)-RA0511 in a linear range of 0.18¨C15 ng/mL.